comparemela.com

Kaivan Khavandi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Asthma drug developed by Stevenage scientists shows promise

An experimental asthma drug developed by Stevenage scientists has proved successful in a late-stage trial.

United kingdomKaivan khavandiGunnels wood road

GSK s depemokimab asthma treatment meets endpoints in latest trials

GSK PLC on Tuesday announced positive results from trials of depemokimab, an ultra-long-acting biologic that could simplify treatment options for patients with severe asthma. The SWIFT-1 and SWIFT-2.

Hugh cameronKaivan khavandiAlliance news ltdAlliance newsAll rights

GSK Says Phase 3 Studies Of Depemokimab In Severe Asthma Met Primary Goals

LONDON (dpa-AFX) - GSK plc (GSK.L) Tuesday said its Phase 3 studies dubbed SWIFT-1 and SWIFT-2 evaluating depemokimab in people with severe asthma met primary endpoints.SWIFT-1 and SWIFT-2 trials

City ofUnited kingdomKaivan khavandiGlobal headIhr portfolio

GSK s SWIFT trials show long-acting treatment reduces attacks

GSK s SWIFT trials show long-acting treatment reduces attacks
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Emma walmsleyKaivan khavandi

GSK : announces positive results from phase III severe asthma trials of depemokimab - Form 6-K

a1901p UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 .

United kingdom generalUnited kingdomUnited statesCity ofKaivan khavandiKathleen quinnTim foleyJosh williamsJ clin pharmacolLyndsay meyerJames dodwellNick stoneSteph mountifieldJeff mclaughlinCamilla campbellSarah clements

vimarsana © 2020. All Rights Reserved.